Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk

1. Azad, A.A.
2. Armstrong, A.J.
3. Alcaraz, A.
4. Szmulewitz, R.Z.
5. Petrylak, D.P.
6. Holzbeierlein, J.
7. Villers, A.
8. Alekseev, B.
9. Iguchi, T.
10. Shore, N.D.
11. Gomez-Veiga, F.
12. Rosbrook, B.
13. Lee, H.-J.
14. Haas, G.P.
15. Stenzl, A.